Published in J Biol Chem on March 07, 2011
Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting. J Exp Clin Cancer Res (2016) 1.41
IGFBP-3 and TNF-α regulate retinal endothelial cell apoptosis. Invest Ophthalmol Vis Sci (2013) 1.14
Insulin-like growth factor binding proteins: a structural perspective. Front Endocrinol (Lausanne) (2012) 1.01
Regulation of retinal endothelial cell apoptosis through activation of the IGFBP-3 receptor. Apoptosis (2013) 0.98
Insulin-like growth factor binding protein-3 (IGFBP-3): Novel ligands mediate unexpected functions. J Cell Commun Signal (2013) 0.95
IGFBP-3 inhibits cytokine-induced insulin resistance and early manifestations of atherosclerosis. PLoS One (2013) 0.88
Endoplasmic reticulum stress and the related signaling networks in severe asthma. Allergy Asthma Immunol Res (2014) 0.83
Effect of TGF-β1 Stimulation on the Secretome of Human Adipose-Derived Mesenchymal Stromal Cells. Stem Cells Transl Med (2015) 0.82
Aggravation of post-ischemic liver injury by overexpression of insulin-like growth factor binding protein 3. Sci Rep (2015) 0.79
An ocular view of the IGF-IGFBP system. Growth Horm IGF Res (2013) 0.78
Pioglitazone restores IGFBP-3 levels through DNA PK in retinal endothelial cells cultured in hyperglycemic conditions. Invest Ophthalmol Vis Sci (2014) 0.76
The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities. Kidney Res Clin Pract (2012) 0.76
Mesenchymal Stromal Cells Mitigate Experimental Colitis via Insulin-like Growth Factor Binding Protein 7-mediated Immunosuppression. Mol Ther (2016) 0.75
Suppression of IGF binding protein-3 by palmitate promotes hepatic inflammatory responses. FASEB J (2016) 0.75
Transcriptomic profile of leg muscle during early growth in chicken. PLoS One (2017) 0.75
Involvement of Igf1r in Bronchiolar Epithelial Regeneration: Role during Repair Kinetics after Selective Club Cell Ablation. PLoS One (2016) 0.75
A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A (1998) 24.58
NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol (1998) 21.48
Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol (2007) 10.23
Chemokines and leukocyte traffic. Nature (1998) 9.79
Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev (1995) 9.54
Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem (1999) 8.16
The global burden of asthma. Chest (2006) 5.74
A critical role for eosinophils in allergic airways remodeling. Science (2004) 5.53
Defining a link with asthma in mice congenitally deficient in eosinophils. Science (2004) 5.20
Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med (2006) 4.83
Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev (1999) 4.39
Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature (2002) 4.21
Caspases in apoptosis and beyond. Oncogene (2008) 3.47
Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature (1999) 2.88
Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem (1997) 2.44
The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol (1986) 2.29
Activation of NF-kappaB by FADD, Casper, and caspase-8. J Biol Chem (2000) 2.14
Asthma and inflammation. J Allergy Clin Immunol (1991) 2.13
Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol (2000) 2.12
IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. Proc Natl Acad Sci U S A (2007) 1.88
Targeting TNF-alpha: a novel therapeutic approach for asthma. J Allergy Clin Immunol (2007) 1.80
Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma. Clin Exp Allergy (1998) 1.80
IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development. Proc Natl Acad Sci U S A (2007) 1.77
Unraveling insulin-like growth factor binding protein-3 actions in human disease. Endocr Rev (2009) 1.76
Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J Clin Invest (2003) 1.64
Corticosteroid effects on cell signalling. Eur Respir J (2006) 1.63
Effects of TNF-alpha on expression of ICAM-1 in human airway epithelial cells in vitro. Signaling pathways controlling surface and gene expression. Am J Respir Cell Mol Biol (2000) 1.53
Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem (1993) 1.49
Involvement of the cysteinyl-leukotrienes in allergen-induced airway eosinophilia and hyperresponsiveness in the mouse. Am J Respir Cell Mol Biol (2003) 1.49
Vital functions for lethal caspases. Oncogene (2005) 1.40
Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice. Endocrinology (2001) 1.39
Interleukin-32 induces the differentiation of monocytes into macrophage-like cells. Proc Natl Acad Sci U S A (2008) 1.37
Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res (1991) 1.36
Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation. Circ Res (2009) 1.31
Phosphorylation of IkappaB-alpha inhibits its cleavage by caspase CPP32 in vitro. J Biol Chem (1997) 1.25
Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer. J Biol Chem (2010) 1.20
Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors (1991) 1.15
Interaction of the hepatitis B virus X protein with the Crm1-dependent nuclear export pathway. J Biol Chem (2001) 1.13
Regulation of replicative senescence by insulin-like growth factor-binding protein 3 in human umbilical vein endothelial cells. Aging Cell (2007) 1.11
Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3. Am J Physiol Endocrinol Metab (2009) 1.06
Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease. Curr Drug Targets (2006) 1.05
Insulin-like growth factors I and II in evaluation of growth retardation. J Pediatr (1986) 1.04
p53-Dependent and p53-independent induction of insulin-like growth factor binding protein-3 by deoxyribonucleic acid damage and hypoxia. J Clin Endocrinol Metab (2005) 1.01
Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells. Cancer Res (2004) 1.00
Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis. Endocrinology (2001) 0.98
Expression of insulin-like growth factor binding proteins in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. Am J Respir Cell Mol Biol (1998) 0.96
Mutation of three critical amino acids of the N-terminal domain of IGF-binding protein-3 essential for high affinity IGF binding. J Clin Endocrinol Metab (2001) 0.94
Caspase cleavage product lacking amino-terminus of IkappaBalpha sensitizes resistant cells to TNF-alpha and TRAIL-induced apoptosis. J Cell Biochem (2002) 0.91
Insulin-like growth factor I is a major fibroblast mitogen produced by primary cultures of human airway epithelial cells. Clin Sci (Lond) (1995) 0.89
Role of insulin-like growth factor-I in allergen-induced airway inflammation and remodeling. Cell Immunol (2005) 0.88
Novel actions of IGFBP-3 on intracellular signaling pathways of insulin-secreting cells. Growth Horm IGF Res (2005) 0.88
Evaluation of the anti-inflammatory effect of infliximab in a mouse model of acute asthma. Respirology (2008) 0.88
Relation between serum Insulin-like growth factor-I and insulin-like growth factor-binding protein-3 levels, clinical status and growth parameters in prepubertal cystic fibrosis patients. Pediatr Int (2004) 0.87
The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment. Growth Horm IGF Res (2006) 0.87
Insulin-like growth factor (IGF) binding proteins: the role of serum IGFBPs in regulating IGF availability. Acta Paediatr Scand Suppl (1991) 0.84
Role of insulin-like growth factor binding protein-3 in allergic airway remodeling. Am J Respir Crit Care Med (2009) 0.84
Procaterol inhibits IL-1beta- and TNF-alpha-mediated epithelial cell eosinophil chemotactic activity. Eur Respir J (1999) 0.83
Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control study. Arthritis Res Ther (2007) 0.82
Insulin-like growth factor binding protein-3 in extracellular matrix stimulates adhesion of breast epithelial cells and activation of p44/42 mitogen-activated protein kinase. Endocrinology (2006) 0.82
Inflammatory cytokines in juvenile idiopathic arthritis: effects on physical growth and the insulin-like-growth factor axis. Growth Horm IGF Res (2008) 0.76
Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial. Ann Intern Med (2005) 3.92
Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol (2003) 2.04
Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms. Endocrinology (2006) 1.96
The Prohibitins: emerging roles in diverse functions. J Cell Mol Med (2006) 1.81
Unraveling insulin-like growth factor binding protein-3 actions in human disease. Endocr Rev (2009) 1.76
Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial. Diabetes Care (2003) 1.62
Prohibitin: a potential target for new therapeutics. Trends Mol Med (2005) 1.60
A nationwide study of mass urine screening tests on Korean school children and implications for chronic kidney disease management. Clin Exp Nephrol (2012) 1.50
Fulminant type 1 diabetes mellitus in Korean adolescents. J Pediatr Endocrinol Metab (2011) 1.39
Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase. J Biol Chem (2004) 1.27
A methylome-wide study of aging using massively parallel sequencing of the methyl-CpG-enriched genomic fraction from blood in over 700 subjects. Hum Mol Genet (2013) 1.24
Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer. J Biol Chem (2010) 1.20
Hematuria and proteinuria in a mass school urine screening test. Pediatr Nephrol (2005) 1.17
Sexual dimorphism in innate immunity. Arthritis Rheum (2002) 1.14
Role of sphingosine-1-phosphate phosphohydrolase 1 in the regulation of resistance artery tone. Circ Res (2008) 1.13
Impaired glucose homeostasis in insulin-like growth factor-binding protein-3-transgenic mice. Am J Physiol Endocrinol Metab (2002) 1.09
Effect of intense exercise on inflammatory cytokines and growth mediators in adolescent boys. Pediatrics (2002) 1.09
Connective tissue growth factor/IGF-binding protein-related protein-2 is a mediator in the induction of fibronectin by advanced glycosylation end-products in human dermal fibroblasts. Endocrinology (2002) 1.07
Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obes Res (2004) 1.06
Prohibitin attenuates insulin-stimulated glucose and fatty acid oxidation in adipose tissue by inhibition of pyruvate carboxylase. FEBS J (2006) 1.05
Ethnicity, insulin resistance, and inflammatory adipokines in women at high and low risk for vascular disease. Diabetes Care (2007) 1.04
Omalizumab reverses the phenotypic and functional effects of IgE-enhanced Fc epsilonRI on human skin mast cells. J Immunol (2007) 1.02
Phosphorylation of histones by tissue transglutaminase. J Biol Chem (2006) 1.01
Insights from insulin-like growth factor binding protein transgenic mice. Endocrinology (2002) 1.01
Insulin-like growth factor-binding protein 3 induces caspase-dependent apoptosis through a death receptor-mediated pathway in MCF-7 human breast cancer cells. Cancer Res (2004) 1.00
Insulin-like growth factor-binding protein-3 suppresses tumor growth via activation of caspase-dependent apoptosis and cross-talk with NF-κB signaling. Cancer Lett (2011) 0.99
Perturbations in bone formation and resorption in insulin-like growth factor binding protein-3 transgenic mice. J Bone Miner Res (2003) 0.99
Genetic basis of Bartter syndrome in Korea. Nephrol Dial Transplant (2011) 0.98
Transglutaminase 2 kinase activity facilitates protein kinase A-induced phosphorylation of retinoblastoma protein. J Biol Chem (2007) 0.96
Familial renal glucosuria: a clinicogenetic study of 23 additional cases. Pediatr Nephrol (2012) 0.95
Insulin-like growth factor binding protein 3 as an anticancer molecule in Ewing's sarcoma. Int J Cancer (2006) 0.95
Binding properties of insulin-like growth factor binding protein-3 (IGFBP-3), IGFBP-3 N- and C-terminal fragments, and structurally related proteins mac25 and connective tissue growth factor measured using a biosensor. Endocrinology (2002) 0.95
Overexpression of gly56/gly80/gly81-mutant insulin-like growth factor-binding protein-3 in transgenic mice. Endocrinology (2004) 0.94
Plasma adipokines and body composition in response to modest dietary manipulations in the mouse. Obesity (Silver Spring) (2006) 0.94
The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity. Biochem Biophys Res Commun (2005) 0.93
The cost of self-monitoring of blood glucose is an important factor limiting glycemic control in diabetic patients. Diabetes Care (2002) 0.92
High allele frequency of the p.Q258X mutation and identification of a novel mis-splicing mutation in the STAR gene in Korean patients with congenital lipoid adrenal hyperplasia. Eur J Endocrinol (2011) 0.89
Targeting IGF-I, IGFBPs and IGF-I receptor system in cancer: the current and future in breast cancer therapy. Recent Pat Anticancer Drug Discov (2011) 0.89
Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents. Clin Biochem (2011) 0.89
IGFBP-3 inhibits cytokine-induced insulin resistance and early manifestations of atherosclerosis. PLoS One (2013) 0.88
Insulin-like growth factor binding protein-3 interacts with autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and inhibits the AMF/PGI function. Cancer Res (2004) 0.86
Insulin-like growth factor-binding protein-3 mediates high glucose-induced apoptosis by increasing oxidative stress in proximal tubular epithelial cells. Endocrinology (2011) 0.86
Perturbations in adiponectin, leptin and resistin levels in acromegaly: lack of correlation with insulin resistance. Clin Endocrinol (Oxf) (2003) 0.85
Premenopausal sexual dimorphism in lipopolysaccharide-stimulated production and secretion of tumor necrosis factor. J Rheumatol (2004) 0.84
Enhanced expression of insulin-like growth factor binding protein-3 sensitizes the growth inhibitory effect of anticancer drugs in gastric cancer cells. Biochem Biophys Res Commun (2002) 0.84
Insulin-like growth factor binding proteins in development. Adv Exp Med Biol (2005) 0.84
Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome. Clin Endocrinol (Oxf) (2004) 0.83
Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells. Biochem Biophys Res Commun (2005) 0.82
Prohibitin binds to C3 and enhances complement activation. Mol Immunol (2006) 0.82
A case of regression of atypical dense deposit disease without C3 deposition in a child. Korean J Pediatr (2010) 0.82
Interaction of insulin-like growth factor binding protein-3 with latent transforming growth factor-beta binding protein-1. Mol Cell Biochem (2003) 0.82
Phosphorylation of transglutaminase 2 by PKA at Ser216 creates 14-3-3 binding sites. Biochem Biophys Res Commun (2006) 0.81
Targeting insulin-like growth factor-I and insulin-like growth factor-binding protein-3 signaling pathways. A novel therapeutic approach for asthma. Am J Respir Cell Mol Biol (2014) 0.81
c-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells. Biochem Biophys Res Commun (2009) 0.81
The effects of insulin-like growth factor binding protein-3 (IGFBP-3) on T47D breast cancer cells enriched for IGFBP-3 binding sites. Mol Cell Biochem (2004) 0.81
Preproghrelin Leu72Met polymorphism is not associated with type 2 diabetes mellitus. Metabolism (2006) 0.81
Preproghrelin Leu72Met polymorphism in obese Korean children. J Pediatr Endocrinol Metab (2005) 0.80
The effects of growth hormone status on circulating levels of vascular growth factors. Clin Endocrinol (Oxf) (2005) 0.79
Serum insulin-like growth factor-binding protein-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes. J Pediatr Endocrinol Metab (2014) 0.79
IGFBP-3 sensitizes antiestrogen-resistant breast cancer cells through interaction with GRP78. Cancer Lett (2012) 0.79
Stevens-Johnson syndrome in a boy with nephrotic syndrome during prednisolone therapy. Pediatr Nephrol (2003) 0.79
The common exon 3 polymorphism of the growth hormone receptor gene and the effect of growth hormone therapy on growth in Korean patients with Turner syndrome. Clin Endocrinol (Oxf) (2009) 0.79
Tobacco specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone suppresses a newly identified anti-tumor IGFBP-3/IGFBP-3R system in lung cancer cells. Lung Cancer (2013) 0.78
Phosphorylation of insulin-like growth factor (IGF) binding protein-3 by breast cancer cell membranes enhances IGF-I binding. Endocrinology (2003) 0.78
Design and synthesis of regioisomerically pure unsymmetrical xanthene derivatives for staining live cells and their photochemical properties. Bioorg Med Chem Lett (2008) 0.78
Adriamycin inhibits adipogenesis through the modulation of PPARγ and restoration of adriamycin-mediated inhibition of adipogenesis by PPARγ over-expression. Toxicol Mech Methods (2012) 0.78
The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance. Clin Endocrinol (Oxf) (2004) 0.78
Canadian guidelines for the management of adult growth hormone deficiency. Clin Invest Med (2006) 0.78
Efficacy and safety of LB03002, a once-weekly sustained-release human GH for 12-month treatment in Korean children with GH deficiency. Eur J Endocrinol (2013) 0.78
Potential of proteomics towards the investigation of the IGF-independent actions of IGFBP-3. Expert Rev Proteomics (2005) 0.77
Changes in adipokine expression during food deprivation in the mouse and the relationship to fasting-induced insulin resistance. Can J Physiol Pharmacol (2003) 0.77
A multi-institutional analysis of prehospital tourniquet use. J Trauma Acute Care Surg (2015) 0.77
Computed tomographic scan: it's not just about the fracture. J Trauma Acute Care Surg (2014) 0.77
Variations in parametrial white adipose tissue mass during the mouse estrous cycle: relationship with the expression of peroxisome proliferator-activated receptor-gamma and retinoic acid receptor-alpha. Can J Physiol Pharmacol (2006) 0.76
Insulin-like growth factor binding protein-3 enhances etoposide-induced cell growth inhibition by suppressing the NF-κB activity in gastric cancer cells. Mol Cell Biochem (2015) 0.75
Increased Incidence of Blood Product Transfusions among Transplant Patients Treated with Linezolid Therapy: A Retrospective, Cohort Study. Am Surg (2015) 0.75
Geriatric education for surgical residents: identifying a major need. Am Surg (2011) 0.75
MicroRNA-152 Suppresses Human Osteosarcoma Cell Proliferation and Invasion by Targeting E2F Transcription Factor 3. Oncol Res (2017) 0.75
Defining the cervical spine clearance algorithm: A single-institution prospective study of more than 9,000 patients. J Trauma Acute Care Surg (2016) 0.75
Pneumatosis Intestinalis Predictive Evaluation Study: A multicenter epidemiologic study of the American Association for the Surgery of Trauma. J Trauma Acute Care Surg (2017) 0.75
The effects of the insulin-like growth factor-I aptamer, NBI-31772, on glucose homeostasis in the mouse. Can J Physiol Pharmacol (2005) 0.75
Neurologic outcome of acute measles encephalitis according to the MRI patterns. Pediatr Neurol (2003) 0.75